A longitudinal cohort study to identify clinical and blood markers of early pancreas cancer
Categories (click each to see list of all clinical trials associated with that category): GI (ONC)
Current Status: Open
Phase: N/A (Cancer Control)
Principal Investigator: Klute, Kelsey
Contact Information:
Christina Hoy
+1 402-559-1577
choy@nebraskamed.com
Eligibility: https://clinicaltrials.gov/study/NCT03568630?term=NCT03568630&rank=1
Summary
Identifying biomarkers of early pancreatic ductal adenocarcinoma (PDAC) could facilitate screening for individuals at higher than average risk and expedite the diagnosis in individuals with symptoms and substantially improve an individual's chance of surviving the disease.
The investigators propose a longitudinal study of subjects at higher than average risk of PDAC in order to generate clinical data and bank serial blood specimens.